Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Dow
Covington
Chinese Patent Office
Julphar
Healthtrust
Citi
Fish and Richardson

Generated: April 26, 2018

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and fourteen approved drugs.



Summary for Abbott
US Patents:0
Tradenames:92
Ingredients:65
NDAs:114

Drugs and US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 019714-001 Sep 12, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 089579-001 Apr 11, 1989 DISCN No No ➤ Sign Up ➤ Sign Up
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 089580-001 Apr 11, 1989 DISCN No No ➤ Sign Up ➤ Sign Up
Abbott VICOPRIN aspirin; hydrocodone bitartrate TABLET;ORAL 086333-001 Sep 14, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 5,412,095 ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 4,112,097 ➤ Sign Up
Abbott DEPAKOTE CP divalproex sodium TABLET, DELAYED RELEASE;ORAL 019794-002 Jul 11, 1990 4,988,731*PED ➤ Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 4,251,532 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 2009-08-14
➤ Subscribe Capsules 100 mg ➤ Subscribe 2012-10-31
➤ Subscribe Tablets 100 mg ➤ Subscribe 2010-12-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Teva
Moodys
Medtronic
Daiichi Sankyo
Federal Trade Commission
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.